Loading…
Monday, June 25 • 11:00am - 12:15pm
#113: Patient-Focused Medicines Development: Where It has Led Us to Today, What Challenges Remain, and What Do We Still Need to Do to Achieve Success?

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Forum
Level: Basic
CE: ACPE 1.25 Knowledge UAN: 0286-0000-18-526-L04-P; CME 1.25; IACET 1.25; RN 1.25

Using a multi-disciplinary approach, we will take a dynamic look at the experience of those involved in patient engagement, across stakeholder groups representing different regions, to understand how we have collectively moved the needle. As organizations have embarked upon efforts and implemented initiatives, we will provide a bird’s eye view of the impact of patient engagement across various stakeholders.

Learning Objectives

Describe how patient engagement has evolved across stakeholder groups in the past few years; Discuss the impact of collective approaches on patient engagement in medicines development lifecycle; Apply key learnings from collective approaches in their own efforts; Describe recent achievements in patient engagement and identify remaining challenges.

Chair

Lode Dewulf

Speaker

Panelist
David Gray

Panelist
Sarah Krug

Panelist
Pamela Tenaerts

Panelist
Lisa Cone



Speakers
avatar for Lisa Cone

Lisa Cone

Patient, Parkinson's Disease Foundation Initiative
Now retired from corporate leadership roles, Lisa Cone leverages her personal experience as a person with Parkinson’s Disease and her professional experiences working with healthcare providers as a Patient Advocate. She is a volunteer leader within the Parkinson's Foundation's Parkinson's... Read More →
avatar for Lode Dewulf

Lode Dewulf

Chief Patient Officer, Servier
Lode recently joined Servier as Chief Patient Officer, reporting to the CEO, because the Patient IN strategy is a core pillar of Servier’s transformation process RiSe. Lode, a physician with 30y global industry experience, is a known global leader and trusted reference for the development... Read More →
avatar for David Gray

David Gray

Senior Director, Pfizer Inc
David Gray is a Drug Discovery team leader based in Cambridge, MA. He's focused mainly in the Neuroscience and Pain, with experience spanning early preclinical "idea" stage to large scale global development of clinical candidates. Additional areas of interest include effectively incorporating... Read More →
avatar for Sarah Krug

Sarah Krug

Chief Executive Officer, CANCER101
Sarah Krüg is the CEO of CANCER101, a patient advocacy organization whose mission is to help patients and caregivers navigate the cancer journey and partner with their healthcare team to make informed decisions. Sarah is also Founder of the Health Collaboratory, a global innovation... Read More →
avatar for Pamela Tenaerts

Pamela Tenaerts

Executive Director, Clinical Trials Transformation Initiative (CTTI)
Dr. Tenaerts provides senior level oversight of CTTI and directs efforts to effectively engage all stakeholders to improve conduct of clinical trials. She is a member of PCORI's CTAP expert post-award subcommittee and MIT Collaborative Initiatives Clinical Trials Process Expert Advisory... Read More →


Monday June 25, 2018 11:00am - 12:15pm
Room 151AB Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA
  • Level Beginner
  • format json
  • Credit Type ACPE, CME, IACET, RN
  • Tags Forum